Publication

Islet Encapsulation: New Developments for the Treatment of Type 1 Diabetes

Related publications (40)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Islet Encapsulation: New Developments for the Treatment of Type 1 Diabetes

Graph Chatbot

Chat with Graph Search

Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2

Transfer of Type 1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID)

Differential expression of neural cell adhesion molecule and cadherins in pancreatic islets, glucagonomas, and insulinomas

Cellular and subcellular localization of an Mr 64,000 protein autoantigen in insulin-dependent diabetes

Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase

Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes

Islet cell and 64K autoantibodies are associated with plasma IGG in newly diagnosed insulin-dependant diabetic children

Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins

Islet Transplantation in Mice Differing in the I and S Subregions of the H-2 Complex

Expression of major histocompatibility antigens on pancreatic-islet cells